Literature DB >> 24476551

New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state.

Nina Kimer1, Jens Peter Goetze, Flemming Bendtsen, Søren Møller.   

Abstract

BACKGROUND: Patients with cirrhosis have substantial circulatory imbalance between vasoconstrictive and vasodilating forces. The study of circulatory vasoactive peptides may provide important pathophysiological information. This study aimed to assess concentrations, organ extraction and relations to haemodynamic changes in the pro-peptides copeptin, proadrenomedullin and pro-atrial natriuretic peptide (proANP) in patients with cirrhosis.
MATERIALS AND METHODS: Fifty-four cirrhotic patients and 15 controls were characterized haemodynamically during a liver vein catheterization. Copeptin, proadrenomedullin and proANP were measured in hepatic and renal veins and the femoral artery.
RESULTS: We found no differences in concentrations of copeptin and proadrenomedullin between patients and controls. ProANPs were higher in cirrhotic patients, median 138 pm (25/75 percentiles 101-194) compared with controls, median 91 pm (25/75 percentiles 82-153) P=0·02. ProANPs were higher in the femoral artery and renal vein, median 140 pm and 116 pm (25/75 percentiles 109-191 and 92-164, respectively), compared with controls, median 99 and 81 (25/75 percentiles 85-146 and 66-123) P=0·02 and P=0·007, respectively. We found no extraction of copeptin, proadrenomedullin or proANP over the liver. Copeptin correlated with portal pressure (R=0·50, P<0·001). Proadrenomedullin correlated with portal pressure (R=0·48, P<0·001) and heart rate (R=0·36, P<0·01). ProANP correlated with cardiac output (R=0·46, P<0·002) and portal pressure (R=0·32, P<0·02). All propeptides correlated with Child score (R>0·31, P<0·03).
CONCLUSIONS: Pro-atrial natriuretic peptide is elevated in cirrhosis. Copeptin, proadrenomedullin and proANP are related to portal pressure and seem associated with systemic haemodynamics. These propeptides may participate in development and perpetuation of vasodilatation and hyperdynamic circulation in cirrhosis.
© 2014 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Cirrhosis; copeptin; haemodynamics; portal hypertension; proadrenomedullin; proatrial natriuretic peptide

Mesh:

Substances:

Year:  2014        PMID: 24476551     DOI: 10.1111/eci.12249

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

Review 1.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

2.  Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.

Authors:  Annarein J C Kerbert; Len Verbeke; Fang W T Chiang; Wim Laleman; Johan J van der Reijden; Wim van Duijn; Frederik Nevens; Ron Wolterbeek; Bart van Hoek; Hein W Verspaget; Minneke J Coenraad
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

3.  Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.

Authors:  Annarein J C Kerbert; Hein W Verspaget; Àlex Amorós Navarro; Rajiv Jalan; Elsa Solà; Daniel Benten; François Durand; Pere Ginès; Johan J van der Reijden; Bart van Hoek; Minneke J Coenraad
Journal:  Crit Care       Date:  2017-12-21       Impact factor: 9.097

4.  Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications.

Authors:  Ahmed Khaled Tawfik; Amal Helmy; Mohamed Yousef; Sabry Abou-Saif; Abdelrahman Kobtan; Eman Asaad; Sherief Abd-Elsalam
Journal:  Hepat Med       Date:  2018-09-04

5.  Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.

Authors:  Emilie Garnæs; Christian Mortensen; Lise Hobolth; Ove Andersen; Jan Nehlin; Søren Møller
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.